Read more
Our understanding of cancer has expanded in multiple directions including pathophysiological, biochemical, toxicological, and pharmacological aspects. Collectively, these areas will strengthen the ability to harness the greater benefit of oncology research to improve patient survival and quality of life and this is illustrated in this volume.
List of contents
Overview and Current Status of Cancer; Introduction; Incidence, Mortality, and Prevention; Diagnosis and Pathobiology; Introduction; Diagnosis; Evolutionary Paradigms and Origin of Cancer; Heterogeneity and Dynamics of Cancer; Hallmarks of Cancer; Molecular Biology of Carcinogenesis; Genetic Underpinnings; Epigenetic Underpinnings; Characteristics, Events, and Stages in Tumorigenesis; Introduction; Metastases and the Microenvironment; Cell-of-Origin, Disseminated and Circulating Tumor Cells, and Cancer Stem Cells;Tumor-derived Exosomes and Particles; Oncogenic Viruses;Metabolic Syndrome and Cancer Metabolism; Convoluted Neovascularization; Treatments and Challenges; Introduction; Chemotherapy, Radiotherapy, and Targeted Therapy; Immunotherapy; Drug Resistance and Cellular Reprogramming; Efficient Biomarkers; The Role of Nutraceuticals and Natural Products; Physiologically Relevant Nutrikinetics and Nutridynamics; Additional Remarks, Perspectives, and Conclusions; References
About the author
Franklyn De Silva - S. F. De Silva is a Ph.D. candidate in Pharmacy/ Pharmaceutical Sciences (completion 2022) enrolled in the College of Graduate and Postdoctoral Studies, and the College of Pharmacy and Nutrition, at the University of Saskatchewan, Canada. He is a member of the Drug Discovery and Development Research Group. Franklyn has an AS in Biotechnology from Ellsworth College, Iowa, USA; a BS (double major: Biotechnology and Chemistry, minor in Biology) and MS (Biology: Cell Biology and Molecular Pharmacology) from West Texas A & M University, USA; and completed a biomedical research internship at Texas Tech University Health Sciences Center, USA. He has worked in the USA and Canada as a biomedical research scientist in areas involving cell & molecular biology, medicinal chemistry, pharmaco-kinetics/dynamics, xenobiotics, nutrient transporters, cellular metabolism, small molecule drugs, natural products, and nutraceuticals.
Jane Alcorn - J. Alcorn is Dean and Professor of the College of Pharmacy and Nutrition, University of Saskatchewan. She has a Doctor of Veterinary Medicine from the Western College of Veterinary Medicine, University of Saskatchewan, and a Ph.D. in Pharmaceutical Sciences (Pharmacokinetics) from the University of Kentucky. Jane Alcorn is a member of the Drug Discovery and Development Research Group and the Cannabinoid Research Initiative of Saskatchewan. Jane’s expertise in pharmacokinetics has been applied to numerous collaborative research projects involving cancer and the health benefits of phytochemicals such as flaxseed lignans and the cannabinoids.
Summary
Our understanding of cancer has expanded in multiple directions including pathophysiological, biochemical, toxicological, and pharmacological aspects. Collectively, these areas will strengthen the ability to harness the greater benefit of oncology research to improve patient survival and quality of life and this is illustrated in this volume.
